A federal court order on February 21st signaled that a decision regarding the Success By Health preliminary injunction was imminent, likely within the following week. This came as the court considered new evidence submitted by the company.

Success By Health had filed twenty-four supplementary exhibits on February 19th. The Federal Trade Commission (FTC) did not object to the filing itself but strongly contested the content. The FTC stated these exhibits were filled with factual errors, directly contradicted sworn testimony from the defendants, and largely contained information that should have been presented before or during the court's February 12th hearing. The FTC maintained that none of this late-filed material undermined the substantial evidence already presented, which indicated a high probability of the FTC prevailing on the merits and that the equities favored granting the injunction.

On February 27th, a preliminary injunction was indeed granted against Success By Health and Jay Noland. This ruling followed extensive filings and hearings concerning allegations of deceptive business practices. The FTC had sought the injunction to halt the company's operations while the investigation proceeded. The court's final decision reflected its assessment of the evidence and arguments presented by both parties.